Method for treatment or prevention of osteoporosis in individuals with high bone turnover

Details for Australian Patent Application No. 2005215173 (hide)

Owner Hormos Medical Corporation

Inventors Kangas, Lauri; Blom, Taru; Lammintausta, Risto

Agent Watermark

Pub. Number AU-A-2005215173

PCT Pub. Number WO2005/079776

Priority 10/783,092 23.02.04 US

Filing date 19 January 2005

Wipo publication date 1 September 2005

International Classifications

A61K 31/075 (2006.01) - Ethers or acetals

A61K 31/085 (2006.01)

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/079776 Priority application(s): WO2005/079776

24 September 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name Hormos Medical Corporation, Application No. 2005215173, under INID (71) correct the applicant name to Hormos Medical Ltd.

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215174-Solid formulations of ospemifene

2005215156-Piperazine urea derivatives for the treatment of endometriosis